Bupropion Hydrochloride

Product NDC: 67046-081
Requested package NDC: 67046-081-30
11-digit product format: 670460081
Labeler code: 67046
Product ID: 67046-081_597a1ea2-7f77-1d9a-e053-2991aa0a94b9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: bupropion hydrochloride
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Contract Pharmacy Services-PA
Application: ANDA206556
Marketing category: ANDA
Marketing start: 2016-08-29
Marketing end: 0000-00-00
Substance: BUPROPION HYDROCHLORIDE
Active strength: 150 mg/1
Pharmacologic classes: Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	67046-081	67046-081-30	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206556-001	BUPROPION HYDROCHLORIDE	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL			2016-08-26
A206556-002	BUPROPION HYDROCHLORIDE	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL			2016-08-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL		2016-08-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206556-001	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206556-002	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	2016-08-26	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 52 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206556-001	AB3	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206556-002	AB3	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206556-001	AB3	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206556-002	AB3	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206556-001	AB3	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206556-002	AB3	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206556-001	AB3	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206556-002	AB3	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206556-001	AB3	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206556-002	AB3	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206556-001	AB3	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A206556-002	AB3	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A206556-001	AB3	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A206556-002	AB3	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A206556-001	AB3	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A206556-002	AB3	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A206556-001	AB3	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A206556-002	AB3	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A206556-001	AB3	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A206556-002	AB3	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A206556-001	AB3	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A206556-002	AB3	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A206556-001	AB3	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A206556-002	AB3	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A206556-001	AB3	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A206556-002	AB3	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A206556-001	AB3	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A206556-002	AB3	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A206556-001	AB3	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A206556-002	AB3	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A206556-001	AB3	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A206556-002	AB3	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A206556-001	AB3	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A206556-002	AB3	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A206556-001	AB3	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A206556-002	AB3	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A206556-001	AB3	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A206556-002	AB3	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A206556-001	AB3	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A206556-002	AB3	1	`3f0d92c62455…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4eceb285-f3c7-4092-a21a-4c9f3169f20c	Product name	5	20260220
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
548ba7fd-fd0c-4a21-b2b0-d01bf93143b8	Product name	3	20240209
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
43a1ed49-eae2-4840-8075-cb4b33478540	Product name	1	20230425
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
b8ee525f-67fb-39fb-91da-7e47ac54581d	Product name	5	20200611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
98e65af1-f5d0-75d5-c930-f8a4ce4c3284	Product name	9	20190211
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
e4d463bc-c674-43cb-be06-82786f310d01	Product name	1	20150326
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
0916dcfb-331f-89b1-8eac-6f7dc76d82da	Product name	1	20140508
d7fc3d53-5a6c-de82-2808-1780f175f17e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67046-081-30	2022-01-28	C162847	48780-1	d6a99b39-b6f4-a426-e053-dadaa90af4c2	These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets, (XL), for oral use 081 Initial U.S. Approval: 1985

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
67046-081-30	Bupropion Hydrochloride(XL)	30 in 1 BLISTER PACK	TABLET, EXTENDED RELEASE	30		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67046-081	BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [CONTRACT PHARMACY SERVICES-PA]	1	Legacy NDC, 1 package rows	20170918_597a29c0-b1b2-497b-e053-2a91aa0ad2ba.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bupropion Hydrochloride (XL)	BUPROPION HYDROCHLORIDE	Proficient Rx LP	80f4a4ef-8190-458d-af2e-5daaf32abc01	2023-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206556 application number: ANDA206556
Bupropion Hydrochloride (XL)	BUPROPION HYDROCHLORIDE	Exelan Pharmaceuticals Inc.	8a0781c0-e7d5-498e-b7d3-d6bd457f175f	2023-08-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206556 application number: ANDA206556
Bupropion Hydrochloride (XL)	BUPROPION HYDROCHLORIDE	CIPLA USA INC.,	c2cf79d7-1aba-4391-980b-5e218781f7c6	2020-04-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206556 application number: ANDA206556

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
ZG7E5POY8O	BUPROPION HYDROCHLORIDE	31677-93-7	BUPROPION HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
993541	buPROPion HCl 150 MG 24HR Extended Release Oral Tablet	PSN	597a29c0-b1b2-497b-e053-2a91aa0ad2ba	1
993541	24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet	SCD	597a29c0-b1b2-497b-e053-2a91aa0ad2ba	1
993541	bupropion HCl XL 150 MG 24 HR Extended Release Oral Tablet	SY	597a29c0-b1b2-497b-e053-2a91aa0ad2ba	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
67046-081-30	67046008130	30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (67046-081-30)	2017-09-18	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Bupropion Hydrochloride (XL)	Contract Pharmacy Services-PA \| Coupler Enterprises	2017-09-18	HUMAN PRESCRIPTION DRUG LABEL	1